Follow
Joanne Nash
Joanne Nash
Professor of Neurobiology, University of Toronto, Scarborough
Verified email at utsc.utoronto.ca - Homepage
Title
Cited by
Cited by
Year
PDZ domains in synapse assembly and signalling
CC Garner, J Nash, RL Huganir
Trends in cell biology 10 (7), 274-280, 2000
7002000
Further evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine.
RG Pertwee, SR Fernando, JE Nash, AA Coutts
British journal of pharmacology 118 (8), 2199, 1996
2221996
Interaction of SAP97 with minus-end-directed actin motor myosin VI: implications for AMPA receptor trafficking
H Wu, JE Nash, P Zamorano, CC Garner
Journal of Biological Chemistry 277 (34), 30928-30934, 2002
1902002
Activation of the cannabinoid receptor by Δ9-tetrahydrocannabinol reduces γ-aminobutyric acid uptake in the globus pallidus
YP Maneuf, JE Nash, AR Crossman, JM Brotchie
European journal of pharmacology 308 (2), 161-164, 1996
1541996
Antiparkinsonian actions of ifenprodil in the MPTP-lesioned marmoset model of Parkinson's disease
JE Nash, SH Fox, B Henry, MP Hill, D Peggs, S McGuire, Y Maneuf, ...
Experimental neurology 165 (1), 136-142, 2000
1502000
Development of a unilaterally-lesioned 6-OHDA mouse model of Parkinson's disease
SL Thiele, R Warre, JE Nash
JoVE (Journal of Visualized Experiments), e3234, 2012
1442012
Interactions between Piccolo and the actin/dynamin-binding protein Abp1 link vesicle endocytosis to presynaptic active zones
SD Fenster, MM Kessels, B Qualmann, WJ Chung, J Nash, ...
Journal of Biological Chemistry 278 (22), 20268-20277, 2003
1272003
The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP …
JE Nash, P Ravenscroft, S McGuire, AR Crossman, FS Menniti, ...
Experimental neurology 188 (2), 471-479, 2004
1192004
Antiparkinsonian actions of blockade of NR2B-containing NMDA receptors in the reserpine-treated rat
JE Nash, MP Hill, JM Brotchie
Experimental neurology 155 (1), 42-48, 1999
1111999
A common signaling pathway for striatal NMDA and adenosine A2a receptors: implications for the treatment of Parkinson's disease
JE Nash, JM Brotchie
Journal of Neuroscience 20 (20), 7782-7789, 2000
1092000
Subcellular redistribution of the synapse‐associated proteins PSD‐95 and SAP97 in animal models of Parkinson&s disease and L‐DOPA‐induced dyskinesia
JE Nash, TH Johnston, GL Collingridge, CC Garner, JM Brotchie
The FASEB journal 19 (6), 1-25, 2005
952005
Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: Intrastriatal microinjection studies in the 6‐OHDA‐lesioned rat
JE Nash, JM Brotchie
Movement Disorders: Official Journal of the Movement Disorder Society 17 (3 …, 2002
822002
Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in …
SL Thiele, B Chen, C Lo, TS Gertler, R Warre, JD Surmeier, JM Brotchie, ...
Neurobiology of disease 71, 334-344, 2014
812014
LTP in hippocampal neurons is associated with a CaMKII‐mediated increase in GluA1 surface expression
VJ Appleby, SAL Corrêa, JK Duckworth, JE Nash, J Noël, SM Fitzjohn, ...
Journal of neurochemistry 116 (4), 530-543, 2011
682011
Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant α-synuclein rat model of parkinsonism
JA Gleave, LR Arathoon, D Trinh, KE Lizal, N Giguere, JHM Barber, ...
Neurobiology of disease 106, 133-146, 2017
582017
Disruption of the interaction between myosin VI and SAP97 is associated with a reduction in the number of AMPARs at hippocampal synapses
JE Nash, VJ Appleby, SAL Corrêa, H Wu, SM Fitzjohn, CC Garner, ...
Journal of neurochemistry 112 (3), 677-690, 2010
552010
The multi‐faceted role of mitochondria in the pathology of Parkinson’s disease
D Trinh, AR Israwi, LR Arathoon, JA Gleave, JE Nash
Journal of Neurochemistry 156 (6), 715-752, 2021
432021
Plasma membrane Ca2+-ATPase associates with CLP36, α-actinin and actin in human platelets
LD Bozulic, MT Malik, DW Powell, A Nanez, AJ Link, KS Ramos, WL Dean
Thrombosis and haemostasis 97 (04), 587-597, 2007
432007
Altered function of glutamatergic cortico-striatal synapses causes output pathway abnormalities in a chronic model of parkinsonism
R Warre, S Thiele, S Talwar, M Kamal, TH Johnston, S Wang, D Lam, ...
Neurobiology of Disease 41 (3), 591-604, 2011
392011
Mitochondrial dysfunction precedes other sub-cellular abnormalities in an in vitro model linked with cell death in Parkinson’s disease
CJ Yong-Kee, E Sidorova, A Hanif, G Perera, JE Nash
Neurotoxicity research 21, 185-194, 2012
332012
The system can't perform the operation now. Try again later.
Articles 1–20